Company Profile

Zymosense Inc
Profile last edited on: 10/31/2022      CAGE: 8V1W4      UEI: NLLSAWVUE3M7

Business Identifier: Novel probes for enzyme measurement
Year Founded
2021
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2233 Mckinley Court
Ames, IA 50010
   (515) 441-9169
   N/A
   www.zymosense.com
Location: Single
Congr. District: 04
County: Story

Public Profile

The principals of Zymosense Inc are addressing development of novel probes for onsite and high-throughput enzyme measurement. If accomplished, this would enables rapid evaluation, discovery, and design of new enzymes. A factor in many aspects of the natural world - agriculture, energy, health, diagnostics, bio-fuels etc =- they are nonethe less difficult to measure. Zymosense Inc indicates their intent to focus on development of novel probes for onsite and high-throughput enzyme measurement. If accomplished, these would enable rapid evaluation, discovery, and design of new enzymes.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Nigel Reuel -- Co-founder and President

  Sparsh Agarwal -- Research Associate

  Jade Daws -- Lab Manager

  Reece Gardner -- Laboratory Intern

  Nathaniel Kallmyer -- Co-Founder and Vice President of Technology

Company News

There are no news available.